Since cholecystokinin (CCK) is known to be anxiogenic in experimental
animals an to induce panic attacks in humans, lymphocyte CCK-8 concent
rations were measured in 15 patients with panic disorder and 15 age- a
nd sex-matched healthy subjects. The patients' levels were measured ag
ain after a 30-day course of alprazolam therapy, 1.5 mg/day. The CCK-8
concentrations were significantly lower in the patients than in the c
ontrol subjects and did not change after alprazolam therapy. There was
no correlation between the peptide values and levels of anxiety or fr
equency and severity of panic attacks.